Podcast TCTMD Talking Points TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Severe MR David W. M. Muller walks C. Michael Gibson through the 1 year results from the TENDYNE trial using a new transcatheter device for mitral valve replacement
Podcast TCTMD Talking Points FAVOR II Europe and Japan: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in CAD C. Michael Gibson gets the scoop from Jelmer Westra.
Podcast TCTMD Talking Points DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions C. Michael Gibson gets the details on this randomized trial of bifurcation stenting from Shao-Liang Chen.
Podcast TCTMD Talking Points COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting Listen to C. Michael Gibson in conversation with Giora Weisz.
Podcast TCTMD Talking Points PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and Minorities C. Michael Gibson reviews new registry results with Wayne Batchelor.
Podcast TCTMD Talking Points Episode 30: PARTNER 2 Quality of Life C. Michael Gibson discusses health-status benefits in intermediate-risk patients treated with surgical or transcatheter aortic valve replacement.
Podcast TCTMD Talking Points Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries C. Michael Gibson sits down with Sean Lyden to discuss the results.
Podcast TCTMD Talking Points Episode 28: The AMULET Observational Study C. Michael Gibson speaks with David Hildick-Smith about left atrial appendage closure devices for stroke prevention.
Podcast TCTMD Talking Points Episode 27: The WATCHMAN US Postapproval Study C. Michael Gibson reviews the results with Vivek Reddy.
Podcast TCTMD Talking Points Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis C. Michael Gibson discusses the trial findings with Pamela Douglas.